Search

With its belief in delivering health with health, Santa Farma Pharmaceuticals has been providing products to Turkish medicine in 10 different therapeutic areas for 80 years. As a pharmaceutical manufacturer, its primary goal is to offer the best in terms of health and ensure quality production. With the mission of offering preferred solutions for human health and quality of life, it is experiencing yet another milestone today on the journey it began 80 years ago. With the newly established Cardiometabolic Group, Santa Farma aims to introduce innovative molecules primarily in the field of Cardiovascular Diseases. Santa Farma is excited to bring two new products to healthcare professionals and patients, both of which are effective in the prevention and treatment of critical conditions, particularly thrombosis and embolism.

Santa Farma CEO Sami Kiresepi stated, “With our slogan ‘My trust is strong, my treatment is solid.’ and our aim to provide high-quality and effective service to the cardiology community, we have established our ‘Heart Union’ team. Through this team, we aim to deliver the latest developments and scientific innovations in the sector to physicians and relevant health fields, ensuring patients receive the best treatments. We are here with our new team and products to offer a healthier future, valuing heart and circulatory system health and providing reliable treatments. With the production quality, working principles, and sustainability sensitivity that we have never compromised over our 80-year journey, we aim for success in this area as well.”